Injective drops around 11.5% after breaking below key short-term moving averages
Injective (INJ) fell 11.59% following pronounced intraday selling pressure, even as recent ecosystem upgrades and institutional adoption continued to advance the platform. The scale of the decline is reinforced by the price slipping below both the 20-day and 50-day moving averages, which signals that sellers remain in control in the short to medium term.
Highlights
- Injective completed its Veyra mainnet upgrade with nearly unanimous staker approval, targeting expanded blockchain functionality.
- Total tokenized real estate mortgages on Injective surpassed $1.5 billion, with a single day contribution of $524.8 million from PentivHQ.
- INJ/USD trades below key short- and medium-term moving averages with bearish momentum, expected to range between $5.55 and $7.35 over the next five sessions.
Institutional pilots contrast with persistent downside as upgrade advances
Injective completed its Veyra mainnet upgrade after nearly unanimous approval from stakers, aiming to expand chain functionality. The blockchain surpassed $1.5 billion in tokenized real estate mortgages, with PentivHQ contributing $524.8 million in a single day. SEC filings confirmed the absence of a supply cap for INJ, and quarterly reports indicated $12.86 billion in trading volume and 90,000 daily wallets for Q3 2026. POSCO International and LG CNS initiated tokenization pilots using the Injective platform, accompanied by the launch of a new options primitive for six testnet markets, though price action has remained under broader selling pressure.
Multi-horizon pressure persists as momentum weakens and volatility spikes
INJ/USD is trading below the 20-day and 50-day moving averages at $7.54 and $7.74, respectively, but remains above the 200-day average at $5.9. This configuration points to ongoing short- and medium-term pressure from sellers, while the longer-term trend is still underpinned by a bullish alignment between the 50-day and 200-day moving averages. Immediate focus is on support at $5.9 and resistance at $6.54. Among momentum indicators, the MACD shows bearish momentum and the ADX signals a weak trend. The RSI, Stochastic RSI, and CCI are all neutral, and the Bull/Bear Power (BBP) is barely positive, suggesting a near balance between buyers and sellers. The Awesome Oscillator (AO) is negative, adding to the downside signals. INJ/USD has dropped to $6.51, losing $0.85 or 11.59% today after a $0.26 (3.53%) downside gap. Volatility over the session is elevated at 9.02%.
Earlier, analysts noted that Injective was trading under sustained selling pressure despite positive ecosystem developments and robust protocol usage. This update adds that elevated volatility and technical weakness currently favor a lower trading band, making the $5.9 support level critical to monitor for any potential shift in trend.